MarketBeat Instant News Alerts 2 hours agoUSA Rare Earth Inc. (NASDAQ:USAR) Given Average Rating of "Moderate Buy" by AnalystsMarketBeatUSA Rare Earth Inc. (NASDAQ:USAR - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and four have issued a buy rating on the company.NASDAQ:USARRead USA Rare Earth Inc. (NASDAQ:USAR) Given Average Rating of "Moderate Buy" by Analysts2 hours agoAmerican Resources Corporation (NASDAQ:AREC) Receives Consensus Rating of "Moderate Buy" from AnalystsMarketBeatShares of American Resources Corporation (NASDAQ:AREC - Get Free Report) have received a consensus rating of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have NASDAQ:ARECRead American Resources Corporation (NASDAQ:AREC) Receives Consensus Rating of "Moderate Buy" from Analysts2 hours agoAllot Ltd. (NASDAQ:ALLT) Receives Consensus Recommendation of "Hold" from AnalystsMarketBeatShares of Allot Ltd. (NASDAQ:ALLT - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buyNASDAQ:ALLTRead Allot Ltd. (NASDAQ:ALLT) Receives Consensus Recommendation of "Hold" from Analysts2 hours agoInsmed (NASDAQ:INSM) Coverage Initiated at Wells Fargo & CompanyMarketBeatWells Fargo & Company initiated coverage on shares of Insmed in a research report on Monday. They set an "overweight" rating and a $171.00 price objective on the stock.NASDAQ:INSMRead Insmed (NASDAQ:INSM) Coverage Initiated at Wells Fargo & Company2 hours agoWells Fargo & Company Initiates Coverage on Keros Therapeutics (NASDAQ:KROS)MarketBeatWells Fargo & Company started coverage on shares of Keros Therapeutics in a research report on Monday. They set an "overweight" rating and a $26.00 price objective on the stock.NASDAQ:KROSRead Wells Fargo & Company Initiates Coverage on Keros Therapeutics (NASDAQ:KROS)2 hours agoWells Fargo & Company Initiates Coverage on Liquidia Technologies (NASDAQ:LQDA)MarketBeatWells Fargo & Company assumed coverage on shares of Liquidia Technologies in a research note on Monday. They set an "overweight" rating and a $31.00 price target on the stock.NASDAQ:LQDARead Wells Fargo & Company Initiates Coverage on Liquidia Technologies (NASDAQ:LQDA) Trending News1Stock Traders Purchase Large Volume of Plug Power Call Options (NASDAQ:PLUG)2Traders Purchase Large Volume of Tilray Brands Call Options (NASDAQ:TLRY)3Beyond Meat Target of Unusually Large Options Trading (NASDAQ:BYND)4QuantumScape (NYSE:QS) Trading Down 9% - Here's What Happened5SoFi Technologies (NASDAQ:SOFI) Shares Down 5.1% - Here's What Happened6D-Wave Quantum (NYSE:QBTS) Stock Price Down 8.9% Following Insider Selling7USA Rare Earth (NASDAQ:USAR) Shares Gap Down - Here's What Happened8SoFi Technologies (NASDAQ:SOFI) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoMannKind (NASDAQ:MNKD) Earns Overweight Rating from Analysts at Wells Fargo & CompanyMarketBeatNASDAQ:MNKDRead MannKind (NASDAQ:MNKD) Earns Overweight Rating from Analysts at Wells Fargo & Company2 hours agoPTC Therapeutics (NASDAQ:PTCT) Coverage Initiated by Analysts at Wells Fargo & CompanyMarketBeatNASDAQ:PTCTRead PTC Therapeutics (NASDAQ:PTCT) Coverage Initiated by Analysts at Wells Fargo & Company2 hours agoSavara (NASDAQ:SVRA) Earns Overweight Rating from Analysts at Wells Fargo & CompanyMarketBeatNASDAQ:SVRARead Savara (NASDAQ:SVRA) Earns Overweight Rating from Analysts at Wells Fargo & Company2 hours agoTectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Wells Fargo & CompanyMarketBeatNASDAQ:TECXRead Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Wells Fargo & Company2 hours agoWells Fargo & Company Initiates Coverage on Ultragenyx Pharmaceutical (NASDAQ:RARE)MarketBeatNASDAQ:RARERead Wells Fargo & Company Initiates Coverage on Ultragenyx Pharmaceutical (NASDAQ:RARE)2 hours agoUnited Therapeutics (NASDAQ:UTHR) Coverage Initiated at Wells Fargo & CompanyMarketBeatNASDAQ:UTHRRead United Therapeutics (NASDAQ:UTHR) Coverage Initiated at Wells Fargo & Company2 hours agoWAVE Life Sciences (NASDAQ:WVE) Coverage Initiated at Wells Fargo & CompanyMarketBeatNASDAQ:WVERead WAVE Life Sciences (NASDAQ:WVE) Coverage Initiated at Wells Fargo & Company2 hours agoHovde Group Forecasts Strong Price Appreciation for FinWise Bancorp (NASDAQ:FINW) StockMarketBeatNASDAQ:FINWRead Hovde Group Forecasts Strong Price Appreciation for FinWise Bancorp (NASDAQ:FINW) Stock2 hours agoUnited Airlines (NASDAQ:UAL) Price Target Raised to $138.00MarketBeatNASDAQ:UALRead United Airlines (NASDAQ:UAL) Price Target Raised to $138.002 hours agoIQE (LON:IQE) Stock Price Up 10% - What's Next?MarketBeatLON:IQERead IQE (LON:IQE) Stock Price Up 10% - What's Next?2 hours agoReitar Logtech Holdings Limited (NASDAQ:RITR) Short Interest UpdateMarketBeatNASDAQ:RITRRead Reitar Logtech Holdings Limited (NASDAQ:RITR) Short Interest Update2 hours agoDeutsche Bank Aktiengesellschaft Begins Coverage on Garrett Motion (NYSE:GTX)MarketBeatNYSE:GTXRead Deutsche Bank Aktiengesellschaft Begins Coverage on Garrett Motion (NYSE:GTX)2 hours agoAutolus Therapeutics (NASDAQ:AUTL) Receives "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:AUTLRead Autolus Therapeutics (NASDAQ:AUTL) Receives "Buy" Rating from Needham & Company LLC2 hours agoModerna (NASDAQ:MRNA) Receives Hold Rating from Needham & Company LLCMarketBeatNASDAQ:MRNARead Moderna (NASDAQ:MRNA) Receives Hold Rating from Needham & Company LLC2 hours agoNeedham & Company LLC Reiterates "Buy" Rating for Celcuity (NASDAQ:CELC)MarketBeatNASDAQ:CELCRead Needham & Company LLC Reiterates "Buy" Rating for Celcuity (NASDAQ:CELC)2 hours agoNurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from Needham & Company LLCMarketBeatNASDAQ:NRIXRead Nurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from Needham & Company LLC2 hours agoTrueCar (NASDAQ:TRUE) Earns "Neutral" Rating from BTIG ResearchMarketBeatNASDAQ:TRUERead TrueCar (NASDAQ:TRUE) Earns "Neutral" Rating from BTIG Research2 hours agoDoorDash's (DASH) "Buy" Rating Reaffirmed at BTIG ResearchMarketBeatNASDAQ:DASHRead DoorDash's (DASH) "Buy" Rating Reaffirmed at BTIG Research2 hours agoJefferies Financial Group Issues Positive Forecast for Teekay Tankers (NYSE:TNK) Stock PriceMarketBeatNYSE:TNKRead Jefferies Financial Group Issues Positive Forecast for Teekay Tankers (NYSE:TNK) Stock Price2 hours agoApollo Commercial Real Estate Finance (NYSE:ARI) Upgraded to "Overweight" at JPMorgan Chase & Co.MarketBeatNYSE:ARIRead Apollo Commercial Real Estate Finance (NYSE:ARI) Upgraded to "Overweight" at JPMorgan Chase & Co.2 hours agoKKR Real Estate Finance Trust (NYSE:KREF) Given Neutral Rating at JPMorgan Chase & Co.MarketBeatNYSE:KREFRead KKR Real Estate Finance Trust (NYSE:KREF) Given Neutral Rating at JPMorgan Chase & Co.2 hours agoAllient (NASDAQ:ALNT) Coverage Initiated by Analysts at JPMorgan Chase & Co.MarketBeatNASDAQ:ALNTRead Allient (NASDAQ:ALNT) Coverage Initiated by Analysts at JPMorgan Chase & Co.2 hours agoBarclays Reiterates "Equal Weight" Rating for Astera Labs (NASDAQ:ALAB)MarketBeatNASDAQ:ALABRead Barclays Reiterates "Equal Weight" Rating for Astera Labs (NASDAQ:ALAB)2 hours agoKeyCorp Issues Pessimistic Forecast for Chipotle Mexican Grill (NYSE:CMG) Stock PriceMarketBeatNYSE:CMGRead KeyCorp Issues Pessimistic Forecast for Chipotle Mexican Grill (NYSE:CMG) Stock Price Featured Articles and Offers3 Rare Earth Stocks Powering America’s Critical Minerals BoomBy Ryan Hasson | October 16, 2025An $8 trillion-dollar discovery 17,000 ft underwater From Porter & Company (Ad)JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025Why Congress Is Buying Intuitive Surgical Ahead of EarningsBy Gabriel Osorio-Mazilli | October 14, 2025Palantir’s New Healthcare Deal Boosts AI and Data Reach By Chris Markoch | October 15, 2025Bitcoin grabs headlines, but smart money likes this tokenFrom Crypto 101 Media (Ad)Salesforce’s Long-Awaited Inflection is Here: Rally On!By Thomas Hughes | October 16, 2025Applied Digital’s Shorts Got Squeezed—Now What?By Thomas Hughes | October 13, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
